Hemorrhagic diathesis after prolonged infusion of low molecular weight dextran.
D000783:Aneurysm / Q000150:complications; D002539:Cerebral Arterial Diseases / Q000150:complications; D003404:Creatinine / Q000097:blood / Q000652:urine; D003911:Dextrans / Q000009:adverse effects*; D005169:Factor VIII; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006470:Hemorrhage / Q000188:drug therapy*; D006474:Hemorrhagic Disorders / Q000139:chemically induced*; D006801:Humans; D052177:Kidney Diseases, Cystic / Q000150:complications; D008297:Male; D008875:Middle Aged; D010973:Platelet Adhesiveness / Q000187:drug effects; D011517:Prothrombin Time; D013917:Thrombin; D013925:Thromboplastin
D003911:Dextrans; D005343:Fibrinolytic Agents; D005169:Factor VIII; D013925:Thromboplastin; D003404:Creatinine; D013917:Thrombin